Geron Corp. (GERN)
1.20
-0.01
(-0.83%)
USD |
NASDAQ |
Oct 02, 16:00
1.20
0.00 (0.00%)
After-Hours: 20:00
Geron Enterprise Value : 720.00M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 720.00M |
| October 01, 2026 | 726.42M |
| September 30, 2026 | 739.27M |
| September 29, 2026 | 745.69M |
| September 28, 2026 | 752.12M |
| September 25, 2026 | 758.54M |
| September 24, 2026 | 758.54M |
| September 23, 2026 | 745.69M |
| September 22, 2026 | 790.67M |
| September 21, 2026 | 784.24M |
| September 18, 2026 | 784.24M |
| September 17, 2026 | 797.09M |
| September 16, 2026 | 777.82M |
| September 15, 2026 | 790.67M |
| September 14, 2026 | 829.22M |
| September 11, 2026 | 816.37M |
| September 10, 2026 | 829.22M |
| September 09, 2026 | 848.49M |
| September 08, 2026 | 919.16M |
| September 04, 2026 | 957.71M |
| September 03, 2026 | 919.16M |
| September 02, 2026 | 970.56M |
| September 01, 2026 | 899.89M |
| August 31, 2026 | 906.31M |
| August 28, 2026 | 919.16M |
| Date | Value |
|---|---|
| August 27, 2026 | 932.01M |
| August 26, 2026 | 932.01M |
| August 25, 2026 | 944.86M |
| August 24, 2026 | 925.59M |
| August 21, 2026 | 925.59M |
| August 20, 2026 | 944.86M |
| August 19, 2026 | 970.56M |
| August 18, 2026 | 932.01M |
| August 17, 2026 | 932.01M |
| August 14, 2026 | 893.46M |
| August 13, 2026 | 935.22M |
| August 12, 2026 | 957.71M |
| August 11, 2026 | 996.26M |
| August 10, 2026 | 899.89M |
| August 07, 2026 | 899.89M |
| August 06, 2026 | 957.71M |
| August 05, 2026 | 996.26M |
| August 04, 2026 | 809.94M |
| August 03, 2026 | 771.39M |
| July 31, 2026 | 777.82M |
| July 30, 2026 | 809.94M |
| July 29, 2026 | 848.49M |
| July 28, 2026 | 880.61M |
| July 27, 2026 | 899.89M |
| July 24, 2026 | 861.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Precigen, Inc. | 3.118B |
| Editas Medicine, Inc. | 261.86M |
| Agenus, Inc. | 620.93M |
| Amgen, Inc. | 261.20B |
| BioCryst Pharmaceuticals, Inc. | 2.569B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.68M |
| Revenue (Quarterly) | 57.48M |
| Total Expenses (Quarterly) | 74.16M |
| EPS Diluted (Quarterly) | -0.0249 |
| Gross Profit Margin (Quarterly) | 94.94% |
| Profit Margin (Quarterly) | -29.02% |
| Earnings Yield | -8.72% |
| Normalized Earnings Yield | -7.275 |